Back
Madrigal Pharmaceuticals Vs. Gilead Sciences Industry Stock Comparison
Sell
47
MDGL
Madrigal Pharmaceuticals
Last Price:
244.39
Seasonality Move:
13.53%
Sell
50
GILD
Gilead Sciences
Last Price:
78.72
Seasonality Move:
5.71%
Sell
47
Madrigal Pharmaceuticals (MDGL)
is a Sell
Is Madrigal Pharmaceuticals a Buy, Sell or Hold?
- The current Madrigal Pharmaceuticals [MDGL] share price is $243.89. The Score for MDGL is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
- MDGL is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
50
Gilead Sciences (GILD)
is a Sell
Is Gilead Sciences a Buy, Sell or Hold?
- The current Gilead Sciences [GILD] share price is $78.72. The Score for GILD is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
- GILD is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
MDGL Stock Price Chart
What is Madrigal Pharmaceuticals's stock price today?
-
The Madrigal Pharmaceuticals share price today is $243.89
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MDGL is experiencing slight selling pressure.
GILD Stock Price Chart
What is Gilead Sciences's stock price today?
-
The Gilead Sciences share price today is $78.72
The current trend is moderately bullish and GILD is experiencing slight selling pressure.
MDGL Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -5.09 | Sell |
Relative Strength Index (14 RSI): | 42.81 | Sell |
Chaikin Money Flow: | -95937 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (240.47 - 258.97) | Sell |
Bollinger Bands (100): | (222.69 - 277.75) | Sell |
GILD Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 1.54 | Buy |
Relative Strength Index (14 RSI): | 64.13 | Buy |
Chaikin Money Flow: | -221652 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (73.98 - 78.22) | Buy |
Bollinger Bands (100): | (65.05 - 74.85) | Buy |
MDGL Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 246.68 | Sell |
20-day SMA: | 248.22 | Sell |
50-day SMA: | 265.52 | Sell |
200-day SMA: | 240.96 | Buy |
8-day EMA: | 246.27 | Sell |
20-day EMA: | 250.74 | Sell |
50-day EMA: | 256.36 | Sell |
200-day EMA: | 240.19 | Buy |
GILD Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 78.8 | Sell |
20-day SMA: | 76.36 | Buy |
50-day SMA: | 73.9 | Buy |
200-day SMA: | 73.26 | Buy |
8-day EMA: | 78.47 | Buy |
20-day EMA: | 77.03 | Buy |
50-day EMA: | 74.4 | Buy |
200-day EMA: | 73.05 | Buy |
Madrigal Pharmaceuticals Earnings Growth & MDGL Earnings Dates
- Analysts estimate an earnings decrease this quarter of $2.42 per share, an increase next quarter of $3.05 per share, a decrease this year of $9.33 per share, and an increase next year of $10.92 per share.
Gilead Sciences Earnings Growth & GILD Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.32 per share, an increase next quarter of $0.20 per share, a decrease this year of $2.96 per share, and an increase next year of $3.33 per share.
Madrigal Pharmaceuticals Technical Analysis
Aug 23 | Aug 26 | Aug 27 | Aug 28 | Aug 29 | Aug 30 | Sep 3 | Sep 4 | Sep 5 | Sep 6 | |
---|---|---|---|---|---|---|---|---|---|---|
Aug | Sep | |||||||||
23 | 26 | 27 | 28 | 29 | 30 | 03 | 04 | 05 | 06 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Gilead Sciences Technical Analysis
Aug 23 | Aug 26 | Aug 27 | Aug 28 | Aug 29 | Aug 30 | Sep 3 | Sep 4 | Sep 5 | Sep 6 | |
---|---|---|---|---|---|---|---|---|---|---|
Aug | Sep | |||||||||
23 | 26 | 27 | 28 | 29 | 30 | 03 | 04 | 05 | 06 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |